Search results

Showing results for

The University of Oxford, together with three partner sites in London, Southampton and Bristol, is to launch the first study to assess the safety and immune responses in children and young adults of the ChAdOx1 nCoV-19 coronavirus vaccine.

Developing a global framework to assess a country's readiness and resilience to introduce a new vaccine or improve uptake of an underutilized vaccine.

Monk V. et al, (2026), Expert Rev Vaccines, 25

Spermidine Mitigates Immune Cell Senescence and Boosts Vaccine Responses in Healthy Older Adults-A Pilot Study.

Alsaleh G. et al, (2026), Aging Cell, 25

In silico post-hoc analysis of a clinically tested recombinant West Nile virus envelope protein vaccine.

Reiné J. et al, (2026), Comput Biol Chem, 122

Host-microbial interactions at the nasal mucosa in young children and adults: A retrospective, cross-sectional study.

Reiné J. et al, (2026), Cell Rep, 45

Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections: a secondary analysis of observational data.

Hagedoorn NN. et al, (2026), Vaccine, 85

Antibody fine specificity correlates with protection from malaria for the RTS,S vaccine in young African children: A post hoc analysis of a phase IIb randomised controlled trial.

Hysa A. et al, (2026), PLoS Med, 23

National Cross-Sectional Study Assessing the Positivity Rate and Clinical Manifestations of Human Bocavirus Respiratory Infections Among Hospitalized Children Under 5 Years of Age in Jordan

Abu Lubad M. et al, (2026), Pathogens, 15, 515 - 515

Willingness to accept paediatric blood sample collection for clinical research purposes in Nepal: a qualitative study.

Dahal A. et al, (2026), BMJ Glob Health, 11

Predicting trajectories of illness using RNA velocity of whole blood.

Dunican C. et al, (2026), Nat Commun, 17

Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trial.

Thorn N. et al, (2026), Lancet Infect Dis

Effect of 13-valent pneumococcal conjugate vaccine on experimental carriage at 1-year post-vaccination on rechallenge with Streptococcus pneumoniae serotype 6B in Blantyre, Malawi: a controlled human infection study and longitudinal follow-up of a randomised controlled trial.

Chirwa AE. et al, (2026), Lancet Microbe, 7

"Intranasal vaccination with recombinant human adenovirus encoding the trans-sialidase gene protects mice from lethal subcutaneous and oral Trypanosoma cruzi trypomastigote challenges".

Noronha IH. et al, (2026), J Infect Dis

Evaluation of Salmonella Paratyphi specific antibody quantity and function after vaccination and controlled human infection.

Jones E. et al, (2026), J Immunol, 215

African-specific genetic loci determine iron status and risk of severe malaria and bacteremia in African children.

Muriuki JM. et al, (2026), Nat Commun

Securing the future of immunisation: ESCMID's vision.

Ramasamy MN. et al, (2026), Clin Microbiol Infect, 32, 516 - 518

The association between vaccine coverage and herd protection: exploratory analyses of a cluster-randomised trial of Vi conjugate vaccine.

Zhang Y. et al, (2026), EClinicalMedicine, 94

Paediatric case of invasive group A streptococcal necrotising myositis: diagnostic challenges and lessons learned.

Yusuf S. et al, (2026), Lancet Infect Dis, 26, e259 - e267

Correction: Leveraging paired serology to estimate the incidence of typhoidal Salmonella infection in the STRATAA study.

Walker J. et al, (2026), PLoS Negl Trop Dis, 20

Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026.

Weiss SL. et al, (2026), Pediatr Crit Care Med, 27, 379 - 434

Maternal views on RSV vaccination in the UK's second season.

O'Hagan S. et al, (2026), Lancet Infect Dis, 26, e209 - e211

Search results

Showing results for

Developing a global framework to assess a country's readiness and resilience to introduce a new vaccine or improve uptake of an underutilized vaccine.

Spermidine Mitigates Immune Cell Senescence and Boosts Vaccine Responses in Healthy Older Adults-A Pilot Study.

In silico post-hoc analysis of a clinically tested recombinant West Nile virus envelope protein vaccine.

Host-microbial interactions at the nasal mucosa in young children and adults: A retrospective, cross-sectional study.

Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections: a secondary analysis of observational data.

Antibody fine specificity correlates with protection from malaria for the RTS,S vaccine in young African children: A post hoc analysis of a phase IIb randomised controlled trial.

National Cross-Sectional Study Assessing the Positivity Rate and Clinical Manifestations of Human Bocavirus Respiratory Infections Among Hospitalized Children Under 5 Years of Age in Jordan

Willingness to accept paediatric blood sample collection for clinical research purposes in Nepal: a qualitative study.

Predicting trajectories of illness using RNA velocity of whole blood.

Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trial.

Effect of 13-valent pneumococcal conjugate vaccine on experimental carriage at 1-year post-vaccination on rechallenge with Streptococcus pneumoniae serotype 6B in Blantyre, Malawi: a controlled human infection study and longitudinal follow-up of a randomised controlled trial.

"Intranasal vaccination with recombinant human adenovirus encoding the trans-sialidase gene protects mice from lethal subcutaneous and oral Trypanosoma cruzi trypomastigote challenges".

Evaluation of Salmonella Paratyphi specific antibody quantity and function after vaccination and controlled human infection.

African-specific genetic loci determine iron status and risk of severe malaria and bacteremia in African children.

Securing the future of immunisation: ESCMID's vision.

The association between vaccine coverage and herd protection: exploratory analyses of a cluster-randomised trial of Vi conjugate vaccine.

Paediatric case of invasive group A streptococcal necrotising myositis: diagnostic challenges and lessons learned.

Correction: Leveraging paired serology to estimate the incidence of typhoidal Salmonella infection in the STRATAA study.

Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026.

Maternal views on RSV vaccination in the UK's second season.

Similar stories

Oxford Bundibugyo ebolavirus vaccine candidate receives CEPI backing

Statement on vaccine efforts relating to the Bundibugyo Ebolavirus outbreak in the DRC

Ambitious research aims to develop multivalent vaccines to protect against multiple deadly filoviruses

20 Years of Collaboration between OVG and Paediatric Research Unit, PAHS, Nepal

World's first Phase II Nipah virus vaccine trial launch

First Volunteer Receives Lassa Fever Vaccine in Cutting-edge Oxford Trial

Cookies on this website

Search results

Showing results for

Similar stories